Kevin G. Connors , MBA

Spray Venture Partners
Boston

Prior to founding Spray Venture Partners, Kevin was the founding CEO of Vesica Medical, a company focused on the surgical treatment of female urinary incontinence. Prior to Vesica, Kevin led medical device investment activity at DSV Partners in Newport Beach, California. He has served on the Board of Directors of Vesica (acquired by Boston Scientific), Pilot Cardiovascular (acquired by Bard), Masimo Corp. (in registration). He currently serves on the Board of Endonetics, Circe, MedGenesis, Situs and several other private companies. Kevin received a B.S. in Electrical Engineering from the University of Notre Dame, an M.S. in Electrical Engineering from the University of Dayton, and an M.B.A from Harvard Business School.